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Background: The regulation of ACOT12 by ADP and ATP is thought to occur through oligomerization.
Results: The structures of apo-ACOT12 and ADP-bound ACOT12 reveal new insights into regulation.
Conclusion: ACOT12 is a homotrimer and neither ADP nor ATP alter the oligomeric state of the protein.
Significance: These findings provide the first structural insights in the regulation of this enzyme family.
Acetyl-CoA plays a fundamental role in cell signaling and
metabolic pathways, with its cellular levels tightly controlled
through reciprocal regulation of enzymes that mediate its syn-
thesis and catabolism.ACOT12, the primary acetyl-CoA thioes-
terase in the liver of human, mouse, and rat, is responsible for
cleavage of the thioester bond within acetyl-CoA, producing
acetate and coenzyme A for a range of cellular processes. The
enzyme is regulated by ADP and ATP, which is believed to be
mediated through the ligand-induced oligomerization of the
thioesterase domains, whereby ATP induces active dimers and
tetramers, whereas apo- and ADP-bound ACOT12 are mono-
meric and inactive. Here, using a range of structural and bio-
physical techniques, it is demonstrated that ACOT12 is a trimer
rather than a tetramer and that neitherADPnorATPexert their
regulatory effects by altering the oligomeric status of the
enzyme. Rather, the binding site and mechanism of ADP regu-
lation have been determined to occur through two novel regu-
latory regions, one involving a large loop that links the thioes-
terase domains (Phe154-Thr178), defined here as RegLoop1, and
a second region involving theC terminus of thioesterase domain
2 (Gln304-Gly326), designated RegLoop2. Mutagenesis con-
firmed that Arg312 and Arg313 are crucial for this mode of regu-
lation, and novel interactions with the START domain are pre-
sented together with insights into domain swapping within
eukaryotic thioesterases for substrate recognition. In summary,
these experiments provide the first structural insights into the
regulation of this enzyme family, revealing an alternate hypoth-
esis likely to be conserved throughout evolution.
Acetyl-CoA is one of the most important cellular metabo-
lites, playing a central role in both the metabolism of carbohy-
drates, lipids, and proteins, as well as a range of signaling path-
ways. Its levels in the mitochondria are allosterically regulated
through control of the pyruvate dehydrogenase complex and
enzymes involved in -oxidation that mediate its production
and reciprocally regulated by enzymes of the citric acid cycle
and ketogenic pathways that are responsible for its oxidative
degradation to produce ATP or ketone bodies (1–4). In the
cytoplasm, acetyl-CoA plays important roles in fatty acid syn-
thesis and in the production of key signalingmolecules, includ-
ing acetyl-choline and the HMG-CoA/mevalonic acid pathway
that lead to synthesis of isoprenoids and cholesterol (5). Here,
acetyl-CoA levels are regulated by key enzymes, including
ATP-citrate lyase (6), cytosolic acetyl-CoA synthetase (7), and
acetyl-CoA thioesterase 12 (ACOT12)3 (8, 9).
ACOT12, known also as StarD15 or cytoplasmic acetyl-CoA
hydrolase, is the major cytoplasmic acetyl-CoA thioesterase
expressed in the liver of mouse (10), rat (11), and human (12).
The enzyme is highly conserved, with82% sequence identity
within these species, and all mammalian homologues are com-
prised of twoN-terminal, tandemhotdog domains, and aC-ter-
minal steroidogenic acute regulatory protein-related lipid
transfer (START) domain. Thioesterase activity resides in the
double hotdog thioesterase domains which typically self-asso-
ciate into dimers, trimers, tetramers, or hexamers depending
on the thioesterase family (13–16). Significantly, oligomeriza-
tion of ACOT12 has been suggested to play a key role in its
regulation, where the apo- and ADP-bound forms are believed
to exist as inactive monomers, while ATP is thought to induce
the enzyme into an active dimers and tetramers (14, 17, 18). The
C-terminal START domain in ACOT12 remains to be fullyTheatomiccoordinatesandstructure factors (codes4MOCand4MOB)havebeen
deposited in the Protein Data Bank (http://wwpdb.org/).
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characterized, but related domains have been shown to act in
lipid binding, transferring and sensing domains for phospholip-
ids, sterols, and sphingolipids (19, 20). In humans, there are 15
proteins containing START domains, termed StarD1-StarD15,
8 of which are part of multidomain proteins (20), however
interactions between START and interdomain partners are yet
to be elucidated. ACOT12 is the acyl-CoA thioesterase respon-
sible for hydrolysis of acetyl-CoA in the liver of mouse, rat, and
human (10–12). Acetyl-CoA is an important component in the
biogenic synthesis of signalingmolecules, and togetherwith the
role of the liver in managing and supplying acetyl-CoA and its
metabolic derivatives to other organs, highlights the impor-
tance of ACOT12 and need for a detailed understanding of its
regulation. ACOT12 has shown to be reciprocally regulated by
ADP and ATP, with the current dogma for the mechanism of
regulation, believed to occur through induced oligomerization
of the thioesterase domains, whereby ATP promote these
domains into active dimer and tetramer forms, whereas apo-
and ADP-bound ACOT12 are inactive monomers (10–12, 17).
Here, we describe the crystal structures of the thioesterase
domains of ACOT12 both in the apo- andADP-bound forms to
provide the first structural basis for thioesterase regulation.
Using a range of complementary biophysical techniques, we
demonstrate that neither ADP nor ATP regulate the oligomer-
ization of the enzyme but instead influence the mobility of two
flexible regions critical for thioesterase activity (21). Rather
than forming a tetramer, we show, using crystallography, small
angle x-ray scattering (SAXS), and size exclusion chroma-
tography (SEC), that the enzyme forms a trimer of double
hotdog protomers, revealing a domain-swapping event
between eukaryote thioesterases for substrate recognition.
Finally, we present the first view of the interactions between the
START and juxtapositional thioesterase domains to provide a
detailed account of thioesterase regulation, which is likely to be
conserved throughout evolution.
MATERIALS ANDMETHODS
Expression and Purification—The thioesterase domains of
human ACOT12 (residues 7–336; accession no. NC_000005.9)
were cloned into the pNIC-Bsa4 expression vector at the Struc-
tural Genomics Consortium (Stockholm, Sweden). The protein
was recombinantly expressed as a His-tagged fusion protein in
Escherichia coli BL21(DE3) pLysS or BL21(DE3) gold pRARE2
cells by the addition of 1 mM isopropyl -D-1-thiogalactopy-
ranoside at an OD of 0.6, and growth continued for 21 h at
291–297 K. Cells were harvested by centrifugation and resus-
pended in His buffer A containing 50mM phosphate buffer, pH
8.0, 300 mM NaCl, and 20 mM imidazole. Purification was car-
ried out in very similar fashion in both laboratories and here we
describe the one leading to structures 4MOCand 4MOB.Affin-
ity chromatography (HisTrap HP, GE Healthcare) was per-
formed using His buffer A to load and remove unbound pro-
teins, and a gradient elution up to 500 mM imidazole over 10
columnvolumes used to elute the enzyme. Fractions containing
recombinant ACOT12 were pooled and treated with TEV pro-
tease (15g/ml) for 12 h at 276 K to remove the His-affinity tag
(leaving 2 vector encoded amino acids, Ser and Met). The pro-
tein was further purified by SEC (S200, 26/60 column, GE
Healthcare) in buffer containing 50 mM Tris, pH 7.4, 125 mM
NaCl, and then concentrated to 21 mg/ml using an Amicon
centrifugal filter. The protein for the apo-ACOT12 structure
(PDB code 3B7K) was concentrated to 16.3 mg/ml in a final
buffer containing 20 mM HEPES, 300 mM NaCl, 10% glycerol,
0.5 mM TCEP, pH 7.5. The purity was assessed to be 95% by
SDS-PAGE and stored as 50-l aliquots at 253 K.
Crystallization—Sparse matrix, hanging drop vapor diffu-
sion was used to screen crystallization conditions over a num-
ber of commercially available screens, in both the presence and
absence of ADP (PEG/Ion, PEG/Ion 2, Crystal Screen, and
Crystal Screen 2 from Hampton Research, JCSG, and PACT
fromMolecular Dimensions). Briefly, 1.5l of the protein sam-
ple was combined with an equal volume of reservoir solution
and suspended above the requisite reservoir solution. Apo-
ACOT12 structure was crystallized with 5mM acetyl-CoAwith
23%PEG3350, 350mM sodium thiocyanate. For improved apo-
ACOT12 structure, small hexagonal crystals were obtained
from slightlymodified conditionwithout acetyl-CoA (22%PEG
3350, 400 mM sodium thiocyanate). For ACOT12-ADP, small
cuboidal crystals were obtained from PEG/Ion 42 condition
(20% PEG 3350, 200 mM potassium phosphate dibasic). These
initial crystallization conditions were optimized by screening
around different PEGand salt concentrations until large, single,
diffraction quality crystals were achieved. The final crystalliza-
tion mixture contained PEG 3350, 150 mM potassium phos-
phate dibasic, and 1 mM ADP.
X-rayDataCollectionandStructureDetermination—Cryocrys-
tallographywas undertaken during x-ray diffraction data collec-
tion to minimize radiation damage. Briefly, crystals were
soaked in reservoir solution containing 15% glycerol or 5%
butanediol (PDB code 3B7K) and flash-cooled in liquid nitro-
gen at 100 K. Diffraction data were collected at the Australian
Synchrotron on the MX1 and MX2 crystallography beamlines
and at European SynchrotronRadiation Facility on ID14-1.Dif-
fraction images were indexed, merged, and scaled using
iMOSFLM (22) and AIMLESS (23) or XDS (24). Phases were
determined bymolecular replacement withMolrep (25) using a
dimer generated from Bacillus halodurans ACOT structure
(PDB code 1VPM) or chain A from ACOT7 (PDB code 2Q2B).
Molecular replacement was followed by iterative rounds of
model building with Coot (26) and refinement using PHENIX
Refine (27) or REFMAC5 (28). Structures have been deposited
to the PDB and were assigned codes 3B7K (apo-ACOT12; 2.7
Å), 4MOC (apo-ACOT12; 2.5 Å), and 4MOB (ACOT12-ADP).
Mutagenesis—MutagenesiswasperformedusingtheQuikChange
site-directed mutagenesis kit (Stratagene). Each reaction mix-
ture consisted of 39.3 l of double distilled H2O, 5 l of 10
reaction buffer, 1 l of dNTP mix, 1.25 l each of forward and
reverse primers (100 M), 1 l of PfuUltra HF polymerase and
1.2 l of ACOT12 plasmid. Mixtures were heated to 95 °C for
30 s followed by 16 cycles of 95 °C for 30 s, 55 °C for 1 min, and
68 °C for 7 min. The amplified products were then treated with
the restriction enzymeDpnI (1l of 10 units/l) for 1 h at 37 °C
to digest the remaining nonmutated parental DNA, and then 1
l of treated DNA was transformed into XL1-Blue supercom-
petent cells. The fidelity of the clones was confirmed by DNA
sequencing.
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Activity Assays—Enzyme activity of ACOT12 was measured
spectrophotometrically using a coupled color change reaction
with 5,5-dithiobis-(2-nitrobenzoate) as described previously
(29–32). Each 100-l assay volume contained 10 mM 5,5-
dithiobis-(2-nitrobenzoate) in 100 mM sodium phosphate
buffer, pH 8.0, 6 g of protein, acetyl-CoA at various concen-
trations as specified, and regulatory molecules (ADP, ATP,
GDP, GTP, citric acid, and NADH) at a final concentration of 10
mM. Release of CoA at 412 nmwasmeasured over 20min at 21 °C
ina96-well plate, andactivitywascalculatedusingextinctioncoef-
ficient412 13,600 M1 cm1 (29). Graphpad Prism (version 6)
was used to plot the data and calculate enzyme kinetics.
Small Angle X-ray Scattering—SAXS measurements were
performed on ACOT12 in the absence and presence of ADP
and ATP at the SAXS beamline of the Australian Synchrotron.
Each SAXS measurement represents the average of ten 1-s
exposures and were performed on a dilution series of protein
from 5 to 0.1 mg/ml. To minimize radiation damage, samples
flowed through a 1.5-mm quartz capillary at a rate of 4 l/s. A
Pilatus 1 M detector (Dektris) with a 1.6-m camera length was
used with an x-ray energy of 12 KeV, giving aQ range from 0.01
to 0.5 Å1. Averaging of images, subtraction of blanks, and
radial integration was performed using the beamline control
software ScatterBrain (Australian Synchrotron), and all mea-
surements were made at 25 °C. Scattering intensities I(q) for
sample and buffer were recorded as a function of scattering
vector q. The scattering profiles were calculated after subtract-
ing the scattering contributions of buffer. Theoretical scatter-
ing curves of crystallographic atomic models were computed
using CRYSOL (33).
RESULTS
Structure Determination of ACOT12—As mentioned previ-
ously, ACOT12 is ofmajor importance, and there is a particular
need for a detailed understanding of its regulation. To address
this, because the structural basis for induced oligomerization
and regulation of thioesterases is yet to be elucidated, we set out
to determine the high resolution structures of the ACOT12
thioesterase domains in the absence and presence of ADP to
better understand this regulatory mechanism. The crystals of
the apo-enzyme were initially solved at 2.7 Å resolution. The
asymmetric unit contained a trimer, which did not fit the
oligomerization described in the literature. A large loop on the
outer face of monomer (residues 153–179) did not have elec-
tron density, and density was also missing for the C-terminal
part of the construct. We therefore decided to try to improve
the crystal quality and try to stabilize these regions in the pro-
tein. A new crystal form of the apo-enzyme was discovered
where one monomer was present in the asymmetric unit and
the crystals diffracting to slightly higher resolution (2.5 Å; outer
shell mean(I)/sd(I), 2.3; Rpim, 0.33; Table 1). This crystal struc-
ture provided clear contiguous electron density enabling 267
residues to be modeled (R/Rfree, 0.20/0.25 and good stereo-
chemistry; Table 1), with the exception of two regions corre-
sponding to residues 154–178 and 304–336 similar to the orig-
inal structure. Notably, both of these regions are visible in the
ADP-bound ACOT12 described below. The apo structures are
very similar (average monomer r.m.s.d. of 0.4 Å for C atoms)
with the major differences at the conformations of the surface
exposed residues and in the 10 amino acids preceding the dis-
ordered C-terminal part (modeled only to one chain in the tri-
meric structure). In the following we will discuss the higher
resolution structure unless otherwise stated. The ACOT12
monomer contained two hotdog domains, each comprised of a
5 stranded -sheet enclosing a central -helix, dimerized with
the two central -helices face-to-face, and -sheets associating
through 2 surrounding the central -helices (Fig. 1, A and B).
Coenzyme A (CoA), not added to the crystallization condi-
tions, was identified at one of two symmetry related active sites,
TABLE 1
Data collection and refinement statistics for ACOT12 and ACOT12:ADP
Values in brackets describe the highest resolution shell.
ACOT12 (PDB code 3B7K) ACOT12 (PDB code 4MOC)
ACOT12:ADP
(PDB code 4MOB)
Wavelength (Å) 0.93400 0.9537 0.9537
Resolution range (Å) 2.70–20 (2.70–2.80) 2.50–31.38 (2.50–2.60) 2.40–34.71 (2.40–2.51)
Space group C2221 P321 I23
Unit cell 82.70, 126.05, and 185.34 Å; 90, 90, and 90° 123.55, 123.55, and 49.75 Å, 90, 90, and 120° 138.85 Å; 90°
Total reflections 191,938 (20,062) 116,336 (11,446) 409,008 (46,051)
Unique reflections 26,807 (2737) 14,338 (1505) 17,555 (2114)
Multiplicity 7.2 (7.3) 8.1 (7.6) 23.3 (21.8)
Completeness (%) 99.3 (100) 93.5 (87.6) 100 (100)
Mean I/(I) 12.5 (3.4) 14.9 (2.3) 18.9 (2.6)
Wilson B-factor (Å2) 69.80 42.25 43.61
Rpim 0.116 (0.598)a 0.037 (0.329) 0.030 (0.300)
Rwork 0.23 0.20 0.16
Rfree 0.28 0.25 0.21
No. of atoms 2240 2671
Macromolecules 5917 2169 2576
Ligands 144 48 72
Water 0 71 95
Protein residues 769 273 320
r.m.s.d.
Bonds (Å) 0.008 0.004 0.010
Angles 1.11° 0.86° 1.23°
Ramachandran favored (%) 94.81 95.56 96.86
Ramachandran allowed (%) 4.92 4.44 3.14
Ramachandran outliers (%) 0.27 0.00 0.00
aRmerge value.
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FIGURE 1. Structure of ACOT12. A, domain architecture of ACOT12 comprised of two hotdog domains and C-terminal START domain. B, structure of the
ACOT12 double hotdog domain protomer shown in schematic representation, with each hotdog domain in dark and light shades of the same color for each
protomer. A 90° rotation highlights the presence of a-bulge induced at each dimer interface. C, structure of the ACOT12 quaternary arrangement comprised
of a trimer of hotdog dimers. D, structures of thioesterases containing the same hexameric arrangement built from either three double hotdog dimers
(eukaryotes) or six single hotdogmonomers (prokaryotes). Shown are structures of the thioesterase domains from B. halodurans (PDB code 1VPM (21)) a single
hotdog fold thioesterase that forms a hexamer; the full length structure of ACOT7 (PDB codes 2Q2B and 2V1O (34)) and the structure of the double hotdog
thioesterase from A. tumefaciens (PDB code 2GVH), which forms a back-to-back protomer.
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occupying the interface of the hotdog dimers and inducing a
-bulge (Fig. 2, A and B). That only half of the potential CoA
binding sites contained ligand is similar to that of mouse
ACOT7 (34), and emerging to be a distinguishing feature
between the double hotdog thioesterases found in eukaryotes,
and the single thioesterase domains of prokaryotic thioes-
terases, since the former contain two non-identical tandem
hotdog domains creating symmetry related, but chemically dis-
tinct binding sites, while the latter contain only a single thioes-
terase domain and identical CoA binding sites (see (34) and
discussion for full description). Since the structural basis for the
preference of CoA-binding in eukaryotic thioesterases has yet
to be determined, we superimposed CoA into the non-binding
site, and compared these two pockets. Binding site one (con-
taining CoA in our structure), bound through H-bonding and
salt bridge interactions involving residues clustered into four
regions (R): R1a (TAS55), R1b (STS84), R1c (R144); and R1d
(KFRG237), while superimposition of the CoA molecule onto
binding site two, revealed major clashes with K228 and T257,
corresponding to residues from the analogous regions R2a
and R2b (Fig. 2) respectively.
Interestingly, despite the low sequence identity between
ACOT7 and ACOT12 of 30%, the CoA binding pockets are
well conserved, but located on opposite domains, indicating
that a domain switch for substrate binding has occurred (Fig.
2C). In both cases, the CoA binding site is distinguished by a
TAS bindingmotif in R1a, while the non-CoA binding site con-
tains a less favorable binding pocket and steric clashes. This will
prove to be a useful feature in the prediction of CoA binding
sites in eukaryotic thioesterases. In similar fashion to the CoA
binding site, the active site residues for ACOT12 also reside on
the opposite domains to those for ACOT7, and comprised of
D36 and N195 in ACOT12, equivalent to the ACOT7 active site
(N24, D213) (Fig. 2C) (34). A tunnel protruding from the active
site to the surface of the protein can also be clearly discerned
(Fig. 2D).
While only one ACOT12 molecule was present in the asym-
metric unit of the crystal, the unit cell was comprised of six
ACOT12 protomers arranged as two trimers. Consistent with
this observation, the biological unit assigned by the Proteins
Interfaces Structures and Assemblies (PISA) server, was a
trimer of the monomeric double hotdog protomer (Fig. 1C).
This trimer is similar to the one found in the asymmetric unit of
the other crystal form and it is also consistent with the quater-
nary structure of other related thioesterases, including mouse
ACOT7 (34) and the bacterial thioesterase from Bacillus halo-
durans (21) (Fig. 1D). To confirm the biological assembly
observed in our crystal structure, both SAXS and SEC were
performed. SAXS data confirmed that ACOT12 exists as a
trimer in solution (Fig. 3A;  of 62, 25, 1.3, and 14.4 for mono-
FIGURE 2. The CoA bindingmotif of ACOT12. A, the two potential binding sites for CoA on ACOT12, with binding site I occupied by CoA as demonstrated by
density at both 2 and 5of Fo Fc annealed omitmaps and, in binding site II, a clear lack of density. B, the binding sites for CoA involving four separate binding
regions; R1a (TAS55), R1b (STS84), R1c (Arg144), and R1d (KRFG237) for binding site I, whereas the binding site II contains steric clashes inhibiting CoA from
occupying this site. C, location of CoA binding and active site residues on ACOT12 and ACOT7, demonstrating domain swapping between these two thioes-
terases for these critical functional regions.D, surface representation of ACOT12with CoA shownas sticks and the substrate-binding tunnel is shownas spheres
determined using Caver (38).
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mer, dimer, trimer and tetramer respectively), and was consis-
tent with SEC data (Fig. 3C), confirming that ACOT12, in the
absence of ADP, exists as a trimer, and thus, structurally similar
to ACOT7 and bacterial thioesterases.
Structural elucidation of ACOT12 bound to ADP—The lack
of structural information pertaining to thioesterase regulation
by alloesteric inhibitors represents a major gap in our under-
standing of this enzyme family, and since the structural elu-
cidation of ACOT12 in the non-ADP form appeared to exist
as a trimer of the double hotdog protomers, we set out to
determine how allosteric regulation may perturb oligomeriza-
tion. Attempts to crystallize ACOT12 bound to ADP in the
conditions identified for apo-ACOT12 were unsuccessful, sug-
gesting that the enzyme was adopting a significantly different
conformation. Crystallization conditions producing crystals
with one monomer in the asymmetric unit, diffracting to 2.4 Å
resolution, enabled elucidation of a structure similar to the
non-ADP form, with the two hotdog domains dimerized in the
same face-to-face configuration (Fig. 4), and CoA located in
the same position. One, well defined ADP molecule was iden-
tified (Fig. 5), located at the base of the -sheet, and bound at a
pocket involving residues Asn252, Arg264, Ser283, Arg312, and
Arg313 (Fig. 5,A and B). These residues are well conserved (Fig.
5D), and similarly to ACOT12 bound to CoA, a symmetry
FIGURE 3. SAXS and SECdata confirm the quaternary structure observed from crystallographic data. A, ACOT12 scattering data (red dots) superimposed
on the theoretical scattering curves (blue line) for an ACOT12 monomer, dimer, trimer, and tetramer using CRYSOL with  values of 62, 25, 1.3, and 14.4,
respectively. B, ACOT12-ADP scattering datawith the theoretical scattering curves for ACOT12-ADPmonomer, dimer, trimer, and tetramer superimposedwith
 values of 25, 7, 1.8, and 5.5. C, SEC elution profiles for apo-ACOT12, ACOT12-ADP, and ACOT12-ATP plotted against known molecular weight standards to
assess the native molecular weight demonstrate that neither ADP nor ATP disrupt oligomerization, consistent with the SAXS and crystallographic data.
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related, but non-identical ADP binding site did not contain
ADP (Fig. 5A), due to the presence of steric clashes (Fig. 5B).
Unexpectedly, the quaternary structure was almost identical
to the CoA bound-ACOT12 structure, exhibiting the same
trimer of double hotdog protomer domains (Fig. 4). It is
unlikely that the quaternary structure can be due to crystal arti-
facts due to its similarity to the apo-ACOT12 that was crystal-
lized in two different space groups (r.m.s.d. of trimer of 0.423
Å2), and its similaritywith other thioesterases.Nevertheless, we
set out to also confirm the ACOT12-ADP quaternary structure
in solution, and found that it was not altered by the presence or
absence of ADP ( of 25, 7, 1.8 and 5.5 for monomer, dimer,
trimer and tetramer respectively) in both SAXS and SEC exper-
iments (Fig 3BC).
That the ADP binding site is located on the surface of the
protein and distinct from all inter-domain interfaces, and, that
these interfaces were not altered in either structure, suggests
that it is unlikely for ADP to be exerting its regulatory action by
influencing the oligomeric state of the enzyme (confirmed in
our structural and solution analysis above). Thus, to reveal the
structural basis of ACOT12 regulation, a full comparative anal-
ysis of both the apo- and ADP-bound ACOT12 structures was
undertaken. The most striking difference was that the previ-
ously flexible, unresolved regions in the CoA-bound-ACOT12
structure (residues 154–178, and 304–326), were now well
ordered and clearly visible in the ADP-bound structure. These
large regions were ordered due to interactions between the
ADP phosphate moieties with Arg312 and Arg313, located
within the second of these flexible loops, which in turn, were
bound through a large array of interactions with the first flexi-
ble loop, specifically involving Glu160 and Glu173 bound to
Arg322 and Arg302 respectively; Leu167, Phe169 and Val176 inter-
acting with Asn304; and Ser161 bonding with Arg315. Secondly,
ADP induces a 50o kink in the helix joining the two hotdog
domains at His150, causing residues 151–179 to link over the
C-terminal -helix (residues 308 to 326) locking it in place
(Fig. 4A). Repulsion between positively charged Arg264 and
Arg312Arg313 is removed when negative phosphate binds
forming a sandwich stabilizing the whole loop system to this
conformation. These charges are not present in binding site II
(Fig. 5B). Since flexibility of the C-terminal-helix is critical for
activity (21), ADP binding in this pocket through Arg312 and
Arg313, and the subsequent locking by loop 1 represents an
effective mechanism through which ADP inhibits enzyme
activity, that is distinct from the current ligand induced oligo-
merization model.
Model for enhanced activity in the presence of ATP—Since
ATP is known to exert the opposite regulatory effect of ADP on
ACOT12, a common phenomenon observed in many meta-
bolic enzymes since ADP and ATP are opposing signals for the
energy status of the cell, we assessed whether our model could
account for reciprocal ATP activation of ACOT12. Superposi-
tion of ATP onto ADP reveals that the -phosphate on ATP
clashes with the C-terminal helix (Fig. 5C). This would prevent
it from being tethered and locked in place by loop one, thus,
promoting the mobility of these domains (rather than immobi-
FIGURE 4. Structure of ACOT12-ADP. A, the flexible regions 154–178 and 304–326 are visible in the ACOT12:ADP structure, revealing a 50° kink in the helix
joining the twohotdogdomains (loop I) atHis150, causing residues151–179 to linkover theC-terminal-helix.B, thehexamer arrangementof theACOT12-ADP
demonstrates its similarity to apo-ACOT12.
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lizing them), and providing a structural basis for the switch
between inhibition and activation by ADP and ATP respec-
tively. Indeed, these structural predictions are supported by our
activity andmutagenesis analysis below, while furthermore, the
alternative induced oligomerization mechanism cannot sup-
port the differences between ADP and ATP.
Enzymeactivity and regulation byADP/ATP confirmed through
mutagenesis—To probe the activity and regulation of ACOT12
based onour structural observations, we first assessed the activ-
ity of the ACOT12 and responsiveness to the ADP and ATP
previously reported in the literature (14, 17, 18). We found the
wtACOT12 cleaved acetyl-CoA (100M) at a rate of 0.25mol/
min/mg, comparable to that described previously (11), and was
sensitive toADP (0.07mol/min/mg) andATP (1.6mol/min/
mg) (Fig. 6). Since flexibility of the C-terminal -helix has pre-
viously been shown to be essential for thioesterase activity (21),
and that Arg312 Arg313 was key to this interaction, we designed
a Glu312 Glu313 ACOT12 double mutant to test whether nucle-
otide regulation could be abolished. As predicted by our struc-
turalmodel, themutantwas no longer susceptible to nucleotide
FIGURE 5. ACOT12 binding site of ADP. A, two potential binding sites, with binding site I having clear density at both 2 and 5 in simulated annealed omit
maps and binding site II exhibiting negligible density corresponding to ADP. B, residues involved in binding ADP at the two potential binding sites, with
binding site I utilizing Arg312 and Arg313 to interact with the phosphate of ADP, whereas at binding site II, ADP is inhibited frombinding due to the presence of
Ser88 (equivalent to Gly in binding site I). C, superposition of ATP on the ADP site reveals the -phosphate of ATP clasheswith Arg312 preventing the C-terminal
helix from being locked into place. D, sequence alignment of human, mouse, and rat ACOT12 and ACOT11. The ADP and START domain binding residues are
highlighted in blue and yellow, respectively.
FIGURE 6. ACOT12 activity and regulation activity. A, the ACOT12 thioesterase activity against acetyl-CoA concentration was plotted in GraphPad Prism
using Michaelis-Menten kinetics (left panel). The activity of ACOT12 at 100M acetyl-CoA is enhanced by the presence of ATP and decreased by ADP, but this
regulatory action is abolished in theArg312/313mutant, forwhichATP andADP (orGTPorGDP) showno significant differences (bottompanels, and summarized
in right panel). The results shown in thebottompanelare fromasingle typical experiment repeated twoormore times,withpooleddata shown in the right panel
representing the mean of activity (	) S.D. B, activity curves investigating the activity of ACOT12 and the Arg312/313 mutant over a range of ATP and ADP
concentrations. Using the log concentrations of regulator the IC50 0.07290 mM for ADP and EC50 0.00297 mM for ATP were determined using Graphpad
Prism.
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regulation (Fig. 6) due to the repulsive charges introduced by
these Glu residues (Fig. 6).
Structural insights into thioesterase and START domain
interactions—The human genome encodes 15 START-domain
containing proteins, many of which are fused with other multi-
domain proteins including thioesterases, the metastatic lymph
node 64 protein (MLN64), and the Rho-GTPase-activating-
protein domain, however association between START and
multi-domain proteins has yet to be structurally resolved (20).
Interestingly, the structure of our ADP-bound ACOT12
revealed a 15 residue overlap with the previously published
structure of the START domain from the related homologue,
ACOT11 (35). Superposition of these overlapping domains is
presented in Fig. 7A. Residues 311–326 of our ACOT12-ADP
structure overlapped with residues 312–327 of the START
domain fromACOT11 (containing 55% sequence identity), and
were superimposed with an r.m.s.d. of 0.308 Å2 for C (Fig. 7),
providing amodel with no steric clashes and a binding interface
of approximately 1000 Å2 between the C-terminal thioes-
terase domain and the START. Interactions at the interface,
FIGURE 7. The ACOT12 full-lengthmodel. A, structural alignment and superposition of ACOT12 with ACOT11 through overlapping residues 311–326. B, the
ACOT11 START domain, shown in yellow, superimposed onto the ACOT12-ADP structure using the overlapping residues 311–326. C, the hexameric model of
full-length ACOT12 containing all three START domains. Superimpositions were performed using Coot (26).
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many of which were conserved among human, mouse, and rat
ACOT12 andACOT11 proteins (Fig. 5D), includeGln256 of the
C-terminal thioesterase domain (Ctt) bound to Ser372 of the
STARTdomain; Lys328 Ctt withGlu384 START;Tyr329 Ctt with
Asp385 START, Tyr329 Ctt with Phe388 START, Arg327 Ctt with
Ile330 START, and Tyr329 Ctt with Ile330 START. Significantly,
the interaction between the thioesterase and START domains
is distinct from the ADP-binding pocket, and therefore, it is
unlikely that the STARTdomain plays a role in regulation of the
ACOT12 activity. Interestingly, START domain regulation has
been reported by previous researchers for both ACOT12 (14)
and ACOT11 (36), the mechanism of which is still unknown
and will be the subject of future research.
DISCUSSION
Here, we describe the first ADP-bound structure within this
enzyme family to reveal a novel regulatory mechanism and the
molecular basis for thioesterase regulation. In both ADP-
bound and unbound structures, the enzyme is a trimer of dou-
ble hotdog protomers, confirmed through crystallographic,
SAXS, and SEC analysis. Previous to this report, the regulation
of ACOT12 was believed to be regulated by ADP and ATP
through differential oligomerization (11, 14, 17). These obser-
vations were performed using size exclusion chromatography
and have, to date, not been confirmed with any other biophys-
ical methods. Our structural and biophysical data do not sup-
port such a mechanism because the nucleotide-binding site
does not appear to disrupt (or promote) the binding of the qua-
ternary interfaces or influence the STARTdomain interactions.
Rather, ADP tethers twonovel regulatory regions, 154–178 and
304–326, designated here as RegLoop1 andRegLoop2, through
specific interactions involving Arg312 and Arg313. RegLoop1
further immobilizes RegLoop2 through an extensive array of
interactions, preventing flexibility of the C-terminal -helix,
which has shown to be essential for enzyme activity (21). ATP
appears to reciprocally regulate the enzyme by preventing
immobilization of RegLoop2 due to a steric clash with the
-phosphate.
The presence of CoA in both of our structures infers that the
ligand remained bound to the protein during the purification
process. That only half of the potential CoA-binding sites con-
tained CoAwas strikingly similar to ACOT7; however, that the
two enzymes contained the same active site configuration but
on opposite domains was quite unexpected. This has implica-
tions for the regulatory mechanism described here; because
CoA is binding on the opposite domains, the locking mecha-
nism would no longer be possible in ACOT7, and indeed, this
has been confirmed in our activity assays, where ADP, ATP,
GDP, and GTP do not alter ACOT7 activity. Thus, this mech-
anism of regulation is likely to only be applicable in thioesterase
family members where the CoA binds in the same pocket as
that described here for ACOT12. Interestingly, domain swap-
ping is likely to emerge as a common feature in this enzyme
family and extend beyond the human homologues described
here. For example, most bacteria contain only a single hotdog
domain in this family of enzymes yet maintain the same overall
quaternary structure (Fig. 1D). However, an exception to this
rule, the thioesterase of Argobacterium tumefaciens (Fig. 1D)
contains a double hotdog protomer, where the hotdog domains
bind back to back rather than face to face, yet remarkably still
achieve the same quaternary structure (Fig. 1D). The structural
basis for determining how (and why) these thioesterases can
achieve the same overall quaternary structure through different
protomer arrangements will only be fully elucidated with addi-
tional structural characterization within this enzyme family.
At the CoA site, a -bulge was also observed at the -sheet
interface, becoming a signature feature of CoA-bound thioes-
terases (21, 37). This was recently documented in the analysis of
CoA bound and unbound forms of acyl-CoA thioesterase from
B. halodurans, where the CoA was shown to induce this
-bulge and interaction with the C-terminal -helices of the
hotdog domains. This is now confirmed in human ACOT12
and other higher order thioesterases (PDB codes 1YLI and
2V1O), suggesting that this is likely to be a highly conserved
structural regulatory element within this thioesterase family.
Overall, our structural insights into the regulation of ACOT12
demonstrate a novel mechanism of regulation, distinct from
that which has been proposed previously. Due to the highly
conserved nature of the thioesterase fold, it is likely that other
thioesterases (with the same CoA domain binding configura-
tion) can be regulated by ADP/ATP via a similar mechanism to
that described here.
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